Readership
Biomedical Researchers, Clinicians, Epidemiologists, Health Scientists, Immunologists, Interventionalists, Molecular Biologists, Nuclear Medicine Physicians, Nurse Oncologists, Nurse Practitioners/Physician Assistants, Oncologists, Physician Assistants, Physicians, Physicians - Medicine, Policy Makers, Radiation Oncologists, Radiologists, Residents
Scope
Cancer Prevention Research publishes original studies, reviews, and commentaries in the fields of cancer prevention and interception. The journal comprises preclinical, clinical, translational, and implementation research, with special attention given to molecular discoveries and an emphasis on building translational and mechanistic bridges between the basic, clinical, and population sciences. The editors welcome manuscript submissions that describe mechanisms of carcinogenesis; develop preventive interventions to intercept cancer development at early stages; or evaluate implementation of evidence-based preventive practices. In-scope areas of particular interest follow:
Biology of susceptibility and premalignancy, including mechanistic studies to understand cancer formation and identify molecular targets for cancer prevention.
Risk factors, particularly the following: microbiome and viruses; chronic infection; behavioral and psychosocial factors (including diet, alcohol, vaping/tobacco, and inactivity); obesity; inflammation; metabolism; hormones; genetic risk factors; aging; and environmental carcinogens (including radiation and sunlight).
Multimorbidities of cancer and other chronic diseases, including studies on common pathways that can be targeted both for cancer prevention as well as for overall health improvement.
Risk assessment and cancer screening, including studies on cancer heredity and utilization of machine-learning/artificial intelligence in predicting risk.
Early detection, including studies on new technologies and biomarkers such as liquid biopsy, multicancer/multitarget assays applied in early detection settings, and “-omics” analyses of preneoplasia samples to detect cancer early.
Preclinical studies on preventive interventions and their mechanisms. Preventive interventions of interest include chemoprevention, immunoprevention (including checkpoint inhibitors, immunological approaches to prevention, and vaccination), and nutritional/behavioral prevention. Novel preclinical models (tissue culture and animals) to test preventive strategies are also of interest.
Clinical studies on preventive interventions. Articles may describe prevention-centric clinical trials at any phase.
Dissemination and implementation research. Studies should describe how to implement an evidence-based intervention, practice, or policy in a successful, highly impactful way. Relevant implementation-related concerns, such as effectiveness, efficiency, scaling, required personnel, and eligible participants, should be addressed.
Cancer disparities science that addresses the disproportionate risk that certain groups face. Groups may be affected by disparities on the basis of race, ethnicity, age, gender, sexual orientation/gender identity, socioeconomic status, insurance status, geographic residence, linguistic or cultural isolation, access to care, etc.
Health policy and global cancer control studies that are focused on the discovery or implementation of evidence-based interventions involving educational programs, infrastructures, and delivery of services addressing clinical or social needs to underserved communities.